South Africa

7 Vaccines Approved for Use in South Africa

RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: sahpra.org.za
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: forbes.com
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
6 trials in 1 country
Approval Source: indiatoday.in
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Approval Source: bloomberg.com
Protein Subunit

Serum Institute of India

COVOVAX (Novavax formulation)

Approved in 6 countries
7 trials in 3 countries
Approval Source: seekingalpha.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: forbes.com

22 in Clinical Trials in South Africa

Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries
RNA

Pfizer/BioNTech

BNT162b2 (B.1.1.7)

RNA

Pfizer/BioNTech

BNT162b2 (B.1.1.7 + B.1.617.2)

RNA

Pfizer/BioNTech

BNT162b2 (B.1.617.2)

RNA

Providence Therapeutics Holdings Inc.

PTX-COVID19-B

4 trials in 2 countries
Non Replicating Viral Vector

ImmunityBio Inc

hAd5-Covid-19

7 trials in 2 countries
DNA

Scancell

COVIDITY

RNA

ImmunityBio Inc

AAHI-SC2 Vaccine

2 trials in 1 country
RNA

ImmunityBio Inc

AAHI-SC3 Vaccine

2 trials in 1 country
Protein Subunit

Clover

SCB-2019

15 trials in 13 countries
Protein Subunit

Serum Institute of India

COVOVAX (Novavax formulation)

Approved in 6 countries
7 trials in 3 countries
RNA

Pfizer/BioNTech

Comirnaty Bivalent Original/Omicron BA.1

Approved in 35 countries
3 trials in 5 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Protein Subunit

Clover

SCB-2020S

2 trials in 1 country
RNA

Gritstone bio, Inc.

GRT-R912

RNA

Gritstone bio, Inc.

GRT-R914

RNA

Gritstone bio, Inc.

GRT-R918